BioSpace News Archive

Business

HOX THERAPEUTICS APPOINTS KARL KEEGAN AS CHIEF EXECUTIVE OFFICER

Developing Targeted Therapies With Potential Applicability Across Many Cancer Types

November 21, 2018
·
3 min read
Policy

Medtronic Receives CE Mark Approval for the Valiant Navion(TM) Thoracic Stent Graft System

Lower-Profile Thoracic Endovascular Aortic Repair (TEVAR) Device Broadens Treatable Patient Population with Thoracic Aortic Disease

November 21, 2018
·
3 min read
Job Trends

Understanding Congenital Heart Defects To Prevent Them

UH Engineer Using Optical Equipment to Watch Heart Develop

November 21, 2018
·
2 min read
Artios Pharma Wins 2018 Lifestars EU Private Finance Raise of the Year Award

Artios Pharma Limited is pleased to announce that it has won the 2018 Lifestars “>£30m EU Private Finance Raise of the Year” Award.

November 21, 2018
·
2 min read
Eisai Receives “IR Grand Prix Award”

Eisai Co., Ltd. has announced that it received the “IR Grand Prix Award” at the IR Award 2018 held by the Japan Investor Relations Association (JIRA).

November 21, 2018
·
3 min read
Drug Development

Former AVEO CFO Found Guilty of Misleading Investors

David Johnston, the former chief financial officer of AVEO Oncology, was found guilty of misleading investors about the company’s kidney cancer drug, Tivozanib. Under new leadership, AVEO aims to seek U.S. approval for its kidney cancer drug early next year.

November 21, 2018
·
2 min read
·
Alex Keown
Job Trends

BioSpace Movers and Shakers: Nov. 26

In a short week leading up to Thanksgiving, several companies made leadership changes as they eye the coming year. We round up who made power moves this past week.

November 21, 2018
·
4 min read
·
Alex Keown
Medivir Nominates MIV-828 as a Candidate Drug for the Treatment of Hematological Malignancies

Medivir AB today announces that MIV-828 has been nominated as a candidate drug (CD) for the treatment of acute myeloid leukemia (AML) and other hematological malignancies.

November 21, 2018
·
2 min read
Policy

OBI Pharma Granted FDA Orphan Drug Designation for OBI-888 for the Treatment of Pancreatic Cancer

First Orphan Drug Designation for OBI-888, a novel first-in-class Monoclonal Antibody targeting Globo H, a glycolipid antigen found on multiple tumor types.

November 21, 2018
·
3 min read
Policy

FDA Closes Inquiry Regarding IHCTOA Letter Regarding Sciton’s diVa® Laser

Sciton, Inc. announced today that the FDA has advised the company that it appears that Sciton has satisfactorily addressed all items raised by the FDA in its July 24, 2018 “It Has Come to Our Attention” letter.

November 21, 2018
·
2 min read